News

New therapy for small cell lung cancer offered at Hollings

A doctor in a white coat sits to chat with a patient, who has her back facing the camera

A newly approved targeted therapy for small cell lung cancer patients whose cancer has not responded or stopped responding to chemotherapy is at the forefront of a new type of drug for solid tumors. The team at Hollings is already experienced at delivering the drug, called tarlatamab, having participated in an arm of the clinical trial.

“It will be incredible to have more drugs of this nature, which is where the oncology solid tumor field is moving,” said Mariam Alexander, M.D., Ph.D.

Read about the drug

portrait of researcher Ashish Deshmukh in jacket and collared shirt open at the neck in a sunlit hallway

HPV Vaccine Success

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

cancer and diabetes researcher Leo Ferreira in his lab at Hollings Cancer Center

Tregs to the Rescue

New research shows how Tregs could transform care for type 1 diabetes and eventually cancer and autoimmune diseases.

modern art-esque illustration of a woman on a tightrope balancing geometric shapes in each hand

Caregivers Month

Family caregivers take on medical, physical, social, financial and emotional burdens. It's important to take time to care for themselves as well.

image of a senior scientist and graduate student posing together in the cancer immunology research lab at Hollings Cancer Center

Golgi Stress

New research at Hollings shows how the Golgi body, an organelle within cells, could be a biomarker for T-cell tumor-fighting activity.

a woman in bright pink headband, glasses and earring smiles in a garden setting

Surviving Lung Cancer

Faith and positivity - those are the things that have kept Cynthia Waddy going through the ups and downs of lung cancer treatment.

peering through shelving at a scientist in white coat and blue gloves concentrating on work in the lab

Catalyst Award

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Dr. Joe Delaney in his MUSC Hollings lab

Tackling Cancer Resistance

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

an older couple poses under a brick pergola

Lung Cancer

"If you have life, you have hope," explains lung cancer survivor Juan Ramonell.

a word cloud in the shape of an apple with Quit Smoking being the most prominent and other words including life, muscle and more

Quitting Smoking after Cancer

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.